Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in prospective data from the INTERACTION study

被引：0
|
作者：
Serebruany, V
Midei, M
Malinin, A
Lowry, D
Oshrine, B
Steinhubl, S
Sane, D
Berger, P
Tanguay, JF
O'Connor, C
Hennekens, C
机构：
[1] Sinai Thrombosis Ctr, Baltimore, MD USA
[2] Univ N Carolina, Chapel Hill, NC 27515 USA
[3] Wake Forest Univ, Winston Salem, NC 27109 USA
[4] Mayo Clin, Rochester, NY USA
[5] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[6] Duke Clin Rsch Inst, Durham, NC USA
[7] Univ Miami, Miami, FL 33152 USA
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3065
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [1] Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in prospective data from the interactions of atorvastatin and clopidogrel (INTERACTION) study
    Serebruany, VL
    Midei, MG
    Malinin, AI
    Lowry, DR
    Oshrine, BR
    Steinhubl, SR
    O'Connor, CM
    Hennekens, CH
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 9L - 10L
  • [2] Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in randomized data from the interactions of atorvastatin and clopidogrel (INTERACTION) trial
    Serebruany, VL
    Midel, MG
    Malinin, AI
    Lowry, DR
    Oshrine, BR
    Steinhubl, SR
    O'Connor, CM
    Hennekens, CH
    EUROPEAN HEART JOURNAL, 2003, 24 : 22 - 22
  • [3] Comparison on Long-term Effects of Atorvastatin or Provastatin Combined with Clopidogrel for Patients Undergoing Coronary Stenting
    Zhang, Y.
    Cheng, W. P.
    CARDIOLOGY, 2009, 114 : 22 - 22
  • [4] Comparison on Long-Term Effects of Atorvastatin or Provastatin Combined with Clopidogrel for Patients Undergoing Coronary Stenting
    Zhang, Z. L.
    CARDIOLOGY, 2010, 117 : 38 - 38
  • [5] Omeprazole and atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation in patients undergoing percutaneous coronary intervention in a tertiary health care system: A prospective drug-drug interaction study
    Nagavi, Jinesh Bahubali
    Gurupadayya, Bannimath
    Anantharaju, Preethi Gotadake
    IJC METABOLIC & ENDOCRINE, 2016, 13 : 35 - 40
  • [6] Clopidogrel does not optimally inhibit platelet aggregation in patients undergoing percutaneous coronary intervention. Observations from the DEACON study
    Saucedo, JF
    Aude, W
    Garza, L
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 10L - 11L
  • [7] Interaction of proton pump inhibitors (PPIs) with the antiplatelet effect of clopidogrel in patients undergoing coronary stenting
    Zuern, C. S.
    Geisler, T.
    Lutilsky, N.
    May, A. E.
    Herdeg, C.
    Winter, S.
    Schwab, M.
    Gawaz, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 444 - 444
  • [8] DEVELOPMENT AND IMPLEMENTATION OF A CLOPIDOGREL DESENSITIZATION PROTOCOL FOR PATIENTS WITH CLOPIDOGREL HYPERSENSITIVITY UNDERGOING CORONARY STENTING
    Bucci, C.
    Braga, V.
    Cooper, N.
    Knowles, S.
    Mulholland, K.
    Tsang, L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 159D - 159D
  • [9] CLINICAL SIGNIFICANCE OF THE TREATMENT TIMING OF CLOPIDOGREL IN PATIENTS UNDERGOING CORONARY STENTING
    Chen, I. C.
    Chao, T. H.
    Chang, Y. T.
    Kao, Y. H.
    Tsai, H. S.
    Li, Y. H.
    Lin, L. J.
    Tsai, L. M.
    Chen, J. H.
    ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 167 - 168
  • [10] The antiplatelet response to clopidogrel in diabetic patients undergoing elective coronary stenting
    Bliden, K. P.
    Lawal, L.
    Singla, A.
    Yadav, S.
    DiChiara, J.
    Antonino, M. J.
    Tantry, U. S.
    Saucedo, J. F.
    Gurbel, P. A.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 897 - 898
12345